上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1291Please respect copyright.PENANABVTV2ut9XF
1291Please respect copyright.PENANAoSTcxfgAQ7
上集:https://www.penana.com/article/4711251291Please respect copyright.PENANAy12j6csfrm
1291Please respect copyright.PENANAtDEVGtUDmx1291Please respect copyright.PENANA2Rbl1J6Rny
1291Please respect copyright.PENANA2y0N9u4vDk
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1291Please respect copyright.PENANAHGZ1IGzpwP
1291Please respect copyright.PENANAVYNxOv7LpA
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1291Please respect copyright.PENANAG8Wq5dGKFS
1291Please respect copyright.PENANAmKDr8wXE8L
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1291Please respect copyright.PENANAPZyTqu2rQo
1291Please respect copyright.PENANAsV8lljQSET1291Please respect copyright.PENANAoP7e2NlmYk
1291Please respect copyright.PENANAmTzqRINsGG
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1291Please respect copyright.PENANAGwe2HYzEp8
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1291Please respect copyright.PENANA4g8sGdU1Dy
1291Please respect copyright.PENANAjIyX9DIOcU
忘記甚麼是Neoantigen的話,可重溫上一集。1291Please respect copyright.PENANAFPUXk3fEBa
1291Please respect copyright.PENANAQ9NLiVG7Gz
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1291Please respect copyright.PENANAUIR3jKxyig
1291Please respect copyright.PENANAMH4FJamztf
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1291Please respect copyright.PENANAA7M9FHKopI
1291Please respect copyright.PENANAHr47iTKSmF1291Please respect copyright.PENANAIRNID6bTGK
1291Please respect copyright.PENANAjYslpxWfKa
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1291Please respect copyright.PENANAY8gOq0sody
1291Please respect copyright.PENANAn6cEa8gx59
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1291Please respect copyright.PENANA6yp7X8nn2r
1291Please respect copyright.PENANADC75DofmCw
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1291Please respect copyright.PENANATm0L7QpWO21291Please respect copyright.PENANAtdVikeKDsz
1291Please respect copyright.PENANACDWSXh3SZB
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1291Please respect copyright.PENANAW4L0IgE6us
1291Please respect copyright.PENANAZleND6Upd9
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1291Please respect copyright.PENANATIKj5CCpLO1291Please respect copyright.PENANAH0JWoEp6Eo
1291Please respect copyright.PENANAIPUDRWaCAi
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1291Please respect copyright.PENANASGaPYO7QJW
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1291Please respect copyright.PENANAk0hl3T77Yg
1291Please respect copyright.PENANAsndCFhZgyA
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1291Please respect copyright.PENANAn0hal2Viou
1291Please respect copyright.PENANAlYIjOB0TGg
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1291Please respect copyright.PENANAyGwlZ00O5E
1291Please respect copyright.PENANArIWmWU6Skd
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1291Please respect copyright.PENANAAgUHAKT0YE
1291Please respect copyright.PENANAXjIq6azxQ7
1291Please respect copyright.PENANANEHZPhyAEo
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1291Please respect copyright.PENANAfkqxfQDfRw
1291Please respect copyright.PENANAQS7YxwLjG5
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1291Please respect copyright.PENANADzsEgIX5JE
1291Please respect copyright.PENANAoDAiNy3u82
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1291Please respect copyright.PENANAEYU5Q0w7nW
1291Please respect copyright.PENANAKRtNevCCUE
Link:1291Please respect copyright.PENANAbTbtU9JF1I
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1291Please respect copyright.PENANA7LkdE7mZGj
1291Please respect copyright.PENANApgZk8kPgnw
1291Please respect copyright.PENANA4ucf5Qq7U2
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1291Please respect copyright.PENANA45JnRsA1o3